Identification of Comorbidities and Their Management

  • Benjamin E. Schneider

Weight loss surgery (WLS) has become accepted as a treatment for obesity and many of its comorbidities. Current indications for WLS require that patients with a body mass index between 35 and 40 kg/m2 suffer from severe comorbid disease in order to attain insurance coverage for surgery. Obesity associated diseases including sleep apnea, diabetes, hypertension, cholelithiasis, thrombophlebitis, and pulmonary embolus may all affect surgical morbidity and mortality. Preoperative Identification of existing comorbidities may be necessary in order to secure access to surgical therapy and enable care givers to intervene in order to optimize outcomes.


Obstructive Sleep Apnea Sleep Apnea Rheumatic Fever Nonalcoholic Fatty Liver Disease Weight Loss Surgery 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Selected Reference

  1. Dixon JB. Surgical treatment for obesity and its impact on NASH. Clin Liver Dis 2007;11:86–101CrossRefGoogle Scholar
  2. Gross JB et al. Practice guidelines for the perioperative management of patient with obstructive sleep apnea. Anesthesiology 2006;104:1081–1093PubMedCrossRefGoogle Scholar
  3. Saltzman E, et al. Criteria for patient selection and multidisciplinary evaluation and treatment of the weight loss surgery patient. Obes Res 2005;13:234–243PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Benjamin E. Schneider
    • 1
  1. 1.Harvard Medical SchoolDepartment of Surgery, Beth Israel Deaconess Medical CenterBostonMA

Personalised recommendations